Skip to Main content Skip to Navigation
Journal articles

Circulating tumor cells as a tool for assessing tumor heterogeneity

Abstract : Tumor heterogeneity is the major cause of failure in cancer prognosis and prediction. Accurately detecting heterogeneity for the development of biomarkers and the detection of the clones resistant to therapy is one of the main goals of contemporary medicine. Metastases belong to the natural history of cancer. The present review gives an overview on the origin of tumor heterogeneity. Recent progress has made it possible to isolate and characterize circulating tumor cells (CTCs), which are the drivers of the disease between the primary sites and metastatic foci. The most recent methods for characterizing CTCs are summarized and we discuss the power of CTC profiling for analyzing tumor heterogeneity in early and advanced diseases.
Complete list of metadata

Cited literature [145 references]  Display  Hide  Download
Contributor : Dominique Heymann Connect in order to contact the contributor
Submitted on : Thursday, April 25, 2019 - 12:11:46 PM
Last modification on : Wednesday, November 3, 2021 - 4:36:53 AM


Tellez-Gabriel et al Theranost...
Files produced by the author(s)


  • HAL Id : inserm-02110266, version 1



Marta Tellez-Gabriel, Marie-Françoise Heymann, Dominique Heymann. Circulating tumor cells as a tool for assessing tumor heterogeneity. Theranostics, Ivyspring International Publisher, In press, Epub ahead of print. ⟨inserm-02110266⟩



Les métriques sont temporairement indisponibles